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Abstract 4-Hydroxyderricin (4-HD) is a major
polyphenol of Angelica keiskei (Japanese name
Ashitaba), exhibiting anti-allergic, anti-diabetic, anti-
oxidant, and antitumor effects. The present study was
designed to evaluate the effects of 4-HD on bone
formation and maintenance by using cultured osteo-
clasts and osteoblasts. 4-HD did not affect cell
proliferation of stromal ST2 cells and preosteoblast
MC3T3-E1 cells at concentrations of 1–10 lM. This
compound inhibited the formation of multinucleated
osteoclasts from mouse splenic cells, and we identified
a molecular pathway of osteoclast differentiation
mediated by 4-HD, which led to inhibition of the
expression of receptor activator of nuclear factor-jB
ligand and macrophage-colony stimulating factor in
ST2 cells. By contrast, 4-HD enhanced indices of
osteoblast differentiation, such as alkaline phos-
phatase activity and calcium deposition by
osteoblastic MC3T3-E1 cells, at concentrations of
1–10 lM. Furthermore, we found that 4-HD at 1 lM
attenuated H2O2 levels in MC3T3-E1 cells. Our
findings indicate that 4-HD may have critical effects
on bone formation and maintenance.
Keywords 4-Hydroxyderricin  Polyphenol 
Osteoblast  Osteoclast  Bone
Introduction
Both the formation and maintenance of bone are
controlled by bone-resorbing osteoclasts and bone-
forming osteoblasts. Osteoclasts are multinucleated
giant cells with the ability to resorb mineralized
tissues. They are formed from hematopoietic cells of
the monocyte/macrophage lineage (Udagawa et al.
1990). The development of osteoclasts in culture is
strictly dependent on support provided by osteoblasts
and/or stromal cells (Udagawa et al. 1990). The
formation and activation of osteoclasts are controlled
by the combined actions of receptor activator of
nuclear factor-jB ligand (RANKL) and macrophage
colony-stimulating factor (M-CSF). Here, we formed
multinucleated osteoclasts from splenic cells by co-
culture with stromal ST2 cells that had been stimulated
by activated vitamin D3 (Hagiwara et al. 2008, 2015;
Notoya et al. 2007). Bone formation involves a
complex series of events that include the proliferation
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and differentiation of osteoprogenitor cells, resulting
in the formation of a mineralized extracellular matrix.
The deposition of calcium and the sequential expres-
sion of type I collagen, alkaline phosphatase, and
osteocalcin are known as markers of osteoblastic
differentiation. Several model systems have been
developed for studying the proliferation and differen-
tiation of bone-forming cells in vitro and the molecular
biology of the mineralization process, such as pre-
osteoblastic cells from mouse calvariae (MC3T3-E1
cells) and osteoblast-like cells from rat calvariae
(Bredford et al. 1993; Hagiwara et al. 1996; Liu et al.
1994; Stein et al. 1990). An imbalance of activities
between osteoclasts and osteoblasts leads to bone
metabolic diseases such as osteoporosis and
osteopetrosis.
4-Hydroxyderricin (4-HD) (Fig. 1) is more abun-
dant as aglycone forms, with relative abundances of
1.5% in the stem exudates of Angelica keiskei
(Japanese name, Ashitaka). A number of studies have
shown that this compound possess biological proper-
ties, including antidiabetic (Li et al. 2016; Zhang et al.
2015; Enoki et al. 2007), anti-inflammatory (Yasuda
et al. 2014; Yadav et al. 2011) and antitumor
(Sumiyoshi et al. 2015; Akihisa et al. 2011; Kimura
et al. 2004; Okuyama et al. 1991) activities. However,
little information is available on the effects of 4-HD on
bone metabolism. The present study was designed to
evaluate the in vitro effects of 4-HD on the formation
and maintenance of bone by using cultured mouse
cells. Our results indicate that 4-HD is useful in the
prevention and treatment of osteoporosis.
Materials and methods
Purification of 4-HD from Angelica keiskei
Chalcone-rich powder of Angelica keiskei (Ashitaba
in Japanese) was purchased from Japan Bio Science
Laboratory Co., Ltd (Osaka, Japan). The powder (2 g)
was extracted with 100 ml of ethyl acetate at room
temperature for 1 h. The extract was subjected to silica
gel chromatography equilibrated with hexane/ethyl
acetate (3:1, v/v), and eluted with hexane/ethyl acetate
(1:1, v/v). The eluate containing 4-HD was subjected
to ODS chromatography (Cosmosil C-18 OPN,
Nacalai Tesque, Kyoto, Japan) equilibrated with
100% methanol to give pure 4-HD.
Formation of osteoclastic cells
Multinucleated osteoclastic cells were formed from
spleen cells by co-culture with ST2 cells (RIKEN Cell
Bank, Tsukuba, Japan) that had been stimulated by
100 nM 1a, 25-dihydroxy-vitamin D3 [1a, 25(OH)2
vitamin D3] (Wako Pure Chemical Industries, Ltd.,
Osaka, Japan). ST2 cells (2 9 104 cells/well) in
48-well plates (area of each well, 0.75 cm2) were
pre-cultured with 100 nM 1a, 25(OH)2 vitamin D3 for
1 day to express RANKL. Spleen cells were collected
from the splenic tissues of 6-weeks-old male ddY mice
(Sankyo Labo Service, Tokyo, Japan). Erythrocytes
contaminating the spleen cell fraction were eliminated
by adding 0.83% ammonium chloride in 10 mM Tris–
HCl (pH 7.4) to the cell pellet. Mouse spleen cells
(1 9 105 cells/well) were spread on ST2 cell layers in
48-well plates and cultured in a-Modified minimum
essential medium (a-MEM: Technologies, Inc. Grand
Island, NY, USA), supplemented with 10% fetal
bovine serum (Moregate BioTech, Bulimba, Aus-
tralia), 50 units mL-1 penicillin and 50 lg mL-1
streptomycin (Life Technologies, Inc., Grand Island,
NY, USA), in a humidified atmosphere of 5% CO2 in
air at 37 C for 7 days. Cultures were maintained at
37 C in a humidified atmosphere of 5% CO2 in air.
Fresh medium, 100 nM 1a, 25(OH)2 vitamin D3 and
4-HD were supplied at 2-days intervals. The Institu-
tional Animal Care and Use Committee of Toin
University of Yokohama approved all animal proto-
cols and procedures.
Multinucleated osteoclastic cells formed were fixed
in 3.7% formaldehyde for 5 min and then in a mixture
of ethanol and acetone (1:1; v:v) for 1 min. These cells
were then stained for tartrate resistant acid phos-
phatase (TRAP) activity (Udagawa et al. 1990). TRAP
activity is a marker of multinucleated osteoclasts.
TRAP-positive multinucleated cells (five or more
nuclei) were counted under a microscope (IX70;
Olympus, Tokyo, Japan).Fig. 1 Structure of 4-HD
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Osteoblastic cell cultures
Preosteoblastic MC3T3-E1 cells were obtained from
RIKEN Cell Bank (Tsukuba, Japan). Cells were
maintained in a 55-cm2 dish in a-Modified minimum
essential medium (a-MEM), supplemented with 10%
fetal bovine serum, 50 units mL-1 penicillin and
50 lg mL-1 streptomycin, in a humidified atmo-
sphere of 5% CO2 in air at 37 C. After reaching
70% confluence, cells were detached by treatment
with 0.05% trypsin, replated in either 55-cm2 dishes or
12-well plates (area of each well, 3.8 cm2) at a density
of 1 9 104 cells/cm2, and grown in a-MEM supple-
mented with 10% fetal bovine serum, 50 units mL-1
penicillin, 50 lg mL-1 streptomycin, 5 mM b-glyc-
erophosphate, and 50 lg mL-1 ascorbic acid. Fresh
medium and 4-HD were supplied to cells at 2-days
intervals. MC3T3-E1 cells formed nodules, and min-
eralization of nodules was observed after cultivation
for 2–3 weeks.
Toxicity of 4-HD for cells
ST2 cells and MC3T3-E1 cells were replated in
96-well plates (area of each well, 0.32 cm2) at a
density of 2.5 9 103 cells/cm2 and grown in a-MEM
supplemented with 10% fetal bovine serum,
50 units mL-1 penicillin, 50 lg mL-1 streptomycin,
and 4-HD at various concentrations. After subculture
for 53 or 74 h, the cell layers were washed with RPMI
1640 medium (Life Technologies, Inc., Grand Island,
NY, USA). 3-[4, 5-Dimethylthiazol-2-yl]-2,
5-diphenyltetrazolium bromide (MTT; DOJINDO,
Kumamoto, Japan) reagent (0.5 mg mL-1 RPMI
1640) was added to each well, followed by incubation
for 4 h for formazan formation. After the medium was
removed, dimethyl sulfoxide was added to each well
to dissolve the formazan, and absorbance was mea-
sured at 570 nm.
Measurement of intracellular reactive oxygen
species
Intracellular reactive oxygen species were measured
using the oxidant-sensitive probe 20, 70-dichlorofluo-
rescin diacetate (DCFH-DA). MC3T3-E1 cells
(4 9 104 cells/dish) in 3.5-cm dishes were cultured
for 48 h with subsequent 48-h incubation with 4-HD.
Thereafter, cells were incubated with 50 lM DCF-DA
for 30 min followed by a 30-min incubation with
500 lM H2O2 and washed with Hank’s Balanced Salt
Solution. Fluorescence emission was detected by
confocal laser scanning microscopy at excitation and
emission wavelengths of 488 and 505 nm, respec-
tively. Images were analyzed using a confocal scan-
ning system (TCP SP2; Leica, Tokyo, Japan).
Measurement of alkaline phosphatase activity
MC3T3-E1 cells were subcultured in 12-well plates
(3.8 cm2/well) in a-MEM containing 10% fetal
bovine serum, 5 mM b-glycerophosphate, and
50 lg mL-1 ascorbic acid. After the cells had reached
confluence (day 3), 4-HD was added to cultures at
various concentrations for 9 days. Cells were washed
with 10 mM Tris–HCl, pH 7.2, and were sonicated in
1 mL of 50 mM Tris–HCl (pH 7.2) containing 0.1%
Triton X-100 and 2 mM MgCl2 for 15 s with a
sonicator (Ultrasonic Disruptor UD-201; Tomy Co.,
Tokyo, Japan). Alkaline phosphatase activity was
determined using an established technique with p-
nitrophenyl phosphate as the substrate. Protein con-
centrations were determined using BCA protein assay
reagent (Pierce Chemical Co., Rockford, IL, USA)
with bovine serum albumin as a standard.
Quantitation of calcium deposition
MC3T3-E1 cells were subcultured in a-MEM con-
taining 10% fetal bovine serum, 5 mM b-glycerophos-
phate, and 50 lg mL-1 ascorbic acid. After the cells
had reached confluence (day 3), 4-HD was added at
various concentrations to the culture medium and cells
were subcultured for 11 days. The amount of calcium,
deposited as hydroxyapatite in the cell layer, was
measured as follows: Layers of cells in 12-well plates
(3.8 cm2/well) were washed with PBS and incubated
overnight with 1 mL of 2 N HCl with gentle shaking.
Ca2? ions in the samples were quantitated by the o-
cresolphthalein complexone method with a Calcium C
kit (Wako Pure Chemical Industries). This kit is
specific for Ca2? ions and has a detection limit of
1 lg mL-1. The solution of Ca2? ions (20 mg dL-1)
provided in the kit was used as the standard solution.
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Real-time polymerase-chain-reaction (PCR)
The mRNA expression of RANKL and M-CSF in ST2
cells treated with 100 nM 1a, 25(OH)2 vitamin D3 was
examined by real-time PCR. The RNeasy Mini Kit
(Qiagen K.K., Tokyo, Japan) was used to extract RNA
from cells that had been exposed to 4-HD for 2 days.
Total RNA (1 lg) was reverse transcribed using the
Transcriptor First Strand cDNA Synthesis Kit (Roche,
Tokyo, Japan) with random primers in a 20-lL
reaction mixture according to the manufacturer’s
protocol. Quantitative polymerase chain reaction
analysis was performed with LightCycler 480 System
II (Roche) and LightCycler 480 SYBR Green I Master
(Roche). PCR (95 C for 10 s, 55 C for 10 s, and
72 C for 10 s, for 45 cycles) was performed using
specific primers (sense primer, 50-TGTACTTTC-
GAGCGCAGATG-30, and antisense primer, 50-
CCCACAATGTGTTGCAGTTC-30) for mouse
RANKL, (sense primer, 50-TTGCCAAGGAGGTGT-
CAGAA-30, and antisense primer, 50-TATTGGA-
GAGTTCCTGGAGC-30) for mouse M-CSF, and
(sense primer, 50-ACTTTGTCAAGCTCATTT-30,
and antisense primer, 50-TGCAGCGAACTT-
TATTG-30) for mouse glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). GAPDH was used as an
internal standard for normalization of each sample.
Statistical analysis
Numerical data have been expressed as mean ± S.D.
values of the results from three to four cultures, and the
significance of differences was analyzed by using
ANOVA (Dunnett’s test) or Tukey–kramer. Statistical
significance was set at P\ 0.05. Experiments were
repeated independently in triplicate and the results
were qualitatively identical in every case. Results
from representative experiments are shown.
Results
Toxicity of 4-HD
We evaluated the toxicity of 4-HD for MC3T3-E1
cells and ST2 cells by using the MTT assay. As shown
in Fig. 2, the viability of MC3T3-E1 cells and ST2
cells was significantly increased and decreased at
some concentrations. However, its disparity is not
great. Furthermore, exposure of MC3T3-E1 cells and
ST2 cells to 4-HD at 10 lM did not affect cell
morphological features (data not shown).
Effects of 4-HD on the formation
of multinucleated osteoclasts
Multinucleated osteoclastic cells were formed from
mouse splenic cells in co-culture with ST2 cells which
had been stimulated by 1a, 25(OH)2 vitamin D3.
Figure 3a shows representative results for the detec-
tion of TRAP activity in multinucleated osteoclastic
cells treated with 4-HD at the indicated
0
0.2
0.4
0.6
0.8
*
**
* 
0
0.2
0.4
0.6
0.8
1
**
**
* 
MC3T3-E1 cells
ST2 cells
45 h 71 h
V 1 3 10
4-HD ( M)
V 1 3 10
4-HD ( M)
)
mn
075ta(
ecnabr osb
A
)
mn
075t a(
ecnabr osb
A
48 h
V 1 3 10
4-HD ( M)
72 h
V 1 3 10
4-HD ( M)
**
* 
Fig. 2 Effects of 4-HD on osteoblastic cell viability. MC3T3-
E1 cells and ST2 cells (each 2.5 9 103 cells/well; 96-well
plates) were exposed to 4-HD at various concentrations
(1–10 lM) and were subcultured for indicated periods. After
treatment with 4-HD, the cells were treated with MTT (50 lg/
well) for 4 h, and the absorbance at 570 nm was measured. The
values represent the mean ± S.D. of results from three wells.
Data are representative of results from three separate experi-
ments. *P\ 0.05 versus vehicle (V) and **P\ 0.01 versus V
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concentrations. Formation of TRAP-positive multin-
ucleated osteoclastic cells was dose-dependently
inhibited by the addition of 4-HD (Fig. 3b). Exposure
of 10 lM 4-HD completely inhibited the formation of
multinucleated osteoclastic cells relative to control
cultures treated with the vehicle alone.
Real-time PCR revealed that 4-HD treatment of
ST2 cells dose-dependently decreased RANKL
mRNA expression (Fig. 4a). 4-HD also affected
M-CSF mRNA expression (Fig. 4b).
Effects of 4-HD on cultured osteoblasts
To assess the effects of 4-HD on the differentiation
and mineralization of MC3T3-E1 cells, we added
4-HD to the culture medium of post-proliferative cells
and assayed alkaline phosphatase activity (a middle-
stage marker of osteoblastic differentiation) and
calcium deposition (Fig. 5). 4-HD significantly
increased the activity of alkaline phosphatase in
MC3T3-E1 cells on day 9 when used at 10 lM
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staining for the detection of TRAP activity. 4-HD was added to
cultures at the indicated concentrations. Cultured cells were then
stained for TRAP activity on day 7. Bar = 5 mm. b 4-HD was
added to cultures at the indicated concentrations. Cultured cells
were then stained for TRAP activity on day 7. TRAP-positive
multinucleated cells (five or more nuclei) were counted under a
microscope. Columns and bars show mean ± S.D. values of the
results from five wells. Data are representative of the results of
three separate experiments. *P\ 0.05 versus vehicle (V),
**P\ 0.01 versus vehicle (V)
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4-HD for 2 days. The PCR conditions are described in the
Materials and methods. Data are representative of results from
two separate experiments. Vehicle was represented as 1
123
Cytotechnology (2019) 71:15–22 19
(Fig. 5a). Furthermore, as demonstrated in Fig. 5b,
4-HD dose-dependently enhanced the deposition of
calcium by MC3T3-E1 cells on day 11. Exposure of
MC3T3-E1 cells to 10 lM 4-HD increased the
deposition of calcium by approximately 270% on
day 11, relative to control cultures treated with the
vehicle alone (Fig. 5b).
It has been reported that hydrogen peroxide (H2O2)
suppressed the differentiation of osteoblasts. There-
fore, we examined the effects of 4-HD on H2O2 levels
in MC3T3-E1 cells (Fig. 6). As shown in Fig. 6, 4-HD
at 1 lM decreased H2O2 levels in cells.
Discussion
We screened natural polyphenols for the ability to
regulate the proliferation, differentiation, and function
of cultured osteoclasts and osteoblasts in order to
identify factors that may cause, prevent, or treat bone
metabolic diseases such as osteoporosis and osteopet-
rosis. We had previously reported that genistein
attenuates osteoclastogenesis by decreasing the levels
of receptor activator NF-jB ligand mRNA in
osteogenic/stromal cells (Yamagishi et al. 2001).
Quercetin (Notoya et al. 2004) and curcumin (Notoya
et al. 2006) have been reported to inhibit cultured
osteoblast metabolism. In addition, quercetin (Woo
et al. 2004) and carnosic acid (Hagiwara et al. 2015)
have been found to inhibit osteoclastogenesis.
Recently, we showed that the olive polyphenols
oleuropein and hydroxytyrosol (Hagiwara et al.
2011) and apigenin (Goto et al. 2015) inhibit the
formation of osteoclasts and attenuate bone loss in
OVX mice. Thus, polyphenols regulate bone metabo-
lism in culture via osteoclasts and osteoblasts.
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Fig. 5 Effects of 4-HD on alkaline phosphatase activity and
mineralization of osteoblasts. MC3T3-E1 cells were cultured in
12-well plates (3.8 cm2/well) with a-MEM containing 10%
fetal bovine serum, 5 mM b-glycerophosphate, and
50 lg mL-1 ascorbic acid. After the cells reached confluence
(day 3), 4-HD was added at various concentrations (1–10 lM)
to the culture medium. Fresh medium with test compound was
supplied at 3-days intervals. aAlkaline phosphatase activity was
measured at day 9 as described in the method. b Deposition of
Ca2? ions was measured at day 11. Quantitative analysis of
Ca2? ions was performed as described in the method. All values
represent the mean ± S.D. of the results from three wells. Data
are representative of results from three separate experiments.
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Fig. 6 Effect of 4-HD on intracellular reactive oxygen species
concentrations. Cells were pre-treated with or without 4-HD
(1–10 lM) for 48 h followed by the incubation with 500 lM
H2O2. Intracellular reactive oxygen species concentrations were
assessed as described in the materials and methods. Data are
mean ± S.E. of three to four separate experiments. **P\ 0.01
versus control cells (vehicle)
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In this study, we attempted to clarify the potential
effects of 4-HD on bone metabolism. We found that
4-HD attenuated osteoclast formation a part through
the decrease in expression of RANKL and M-CSF
mRNAs and induced osteoblast differentiation mark-
ers such as alkaline phosphatase activity and calcium
deposition by MC3T3-E1 osteoblasts. These findings
indicate that 4-HD has properties of down-regulation
of osteoclastogenesis and up-regulation of osteoblas-
togenesis in vitro.
It is well known that polyphenols have antioxidant
properties (Rice-Evans et al. 1995). Recent reports
have suggested that reactive oxygen species (ROS)
play an important role in the regulation of cell
proliferation, differentiation and metabolism. In par-
ticular, ROS inhibit the formation of bone by
osteoblastic cells (Hosoya et al. 1998; Lee et al.
2006; Mody et al. 2001). Oxidative stress resulting in
increased levels of intracellular ROS has been
reported to suppress bone metabolism. Arai et al.
(2007) reported that mineralization of MC3T3-E1
cells was reduced by half after a single exposure to
H2O2 within the non-toxic concentration range. In
addition, there have been some reports that H2O2
suppresses differentiation markers such as alkaline
phosphatase activity, type I collagen gene expression,
and the mineralization of osteoblastic cells (Hosoya
et al. 1998; Lee et al. 2006; Mody et al. 2001). We also
reported that carnosic acid attenuated H2O2 levels and
osteoblastic differentiation in osteoblastic MC3T3-E1
cells (Hagiwara et al. 2015). In the present study,
4-HD significantly reduced intracellular H2O2 level of
MC3T3-E1 cells. These results suggest that 4-HD
induces osteoblastic differentiation a part through the
decrease in intracellular H2O2 level of MC3T3-E1
cells.
Ashitaba, a perennial herb growing mainly along
the Pacific coast of Japan, has been used in traditional
food and medicine (Baba et al. 1998). Our results
using cultured cells suggest that 4-HD may be
effective on bone maintenance, if 4-HD was absorbed
into the plasma. It was reported that 4-HD was quickly
absorbed into the plasma after oral administration of
Ashitaba extract in mice (Nakamura et al. 2012). The
concentration of free 4-HD reached 1.2 ± 0.3 lM in
plasma at 2 h after oral administration of Ashitaba
extract at 200 mg/kg body weight. This concentration
is enough to be effective on inhibition of osteoclast
formation and induction of osteoblast differentiation
from our results.
In conclusion, polyphenol 4-HD extracted from
Angelica keiskei (Ashitaba) markedly inhibited the
formation of multinucleated osteoclasts in culture and
induced osteoblastic differentiation. These findings
suggest that 4-HD may provide insights into the
development of tools useful for the prevention and
treatment of osteoporosis.
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